Zimmer Biomet Holdings IncZBH

ZBH current price
$106.74-9.32%

Capital at risk.

1W
-1.65%
1M
-3.15%
3M
-0.42%
6M
+0.17%
1Y
-9.32%
MAX
+6.44%
Calendar
event
Ex dividend date
30 Sept 2024
event_available
Last Dividend Payment
31 Oct 2024
About Zimmer Biomet Holdings Inc
Ticker
info
ZBH
Trading on
info
NYSE
ISIN
info
US98956P1021
Industry
info
Medical Devices
Sector
info
Healthcare
CEO
info
Ivan Tornos
Headquarters
info
345 East Main Street, Warsaw, IN, United States, 46580
Employees
info
18,000
Website
info
zimmerbiomet.com
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest to facilitate healing or reconstruction after open heart surgery, trauma, or for deformities of the chest. It also offers robotic, surgical, and bone cement products. The company's products and solutions are used to treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. It serves orthopedic surgeons, neurosurgeons, hospitals, stocking distributors, healthcare dealers, and other specialists, as well as agents, healthcare purchasing organizations, or buying groups. The company was formerly known as Zimmer Holdings, Inc. and changed its name to Zimmer Biomet Holdings, Inc. in June 2015. Zimmer Biomet Holdings, Inc. was founded in 1927 and is headquartered in Warsaw, Indiana.
Metrics
BasicAdvanced
Market cap
info
$21.3B
P/E ratio
info
20.39
EPS
info
$5.24
Dividend Yield
info
0.90%
Beta
info
1.02
Forward P/E ratio
info
12.47
EBIDTA
info
$2.56B
Ex dividend date
info
2024-09-30
Price & volume
Market cap
info
$21.3B
Average daily volume
info
1.5M
90-day return
info
-0.42%
30-day return
info
-3.15%
7-day return
info
-1.65%
Dividends
Dividend per share
info
$0.96
Dividend yield
info
0.90%
Forward dividend per share
info
$0.96
Forward dividend yield
info
0.90%
Payout ratio
info
12.17%
Valuation
P/E ratio
info
20.39
Forward P/E
info
12.47
PEG ratio
info
1.4
Trailing P/E
info
20.39
Price to sales
info
2.8
Price to book
info
1.72
Earnings
EPS
info
$5.24
EPS estimate (current quarter)
info
$1.73
EPS estimate (next quarter)
info
$2.27
EBITDA
info
$2.56B
Revenues (TTM)
info
$7.6B
Revenues per share (TTM)
info
$37.01
Technicals
Beta
info
1.02
52-week High
info
$133.31
52-week Low
info
$101.47
50-day moving average
info
$107.46
200-day moving average
info
$113.41
Short ratio
info
3.96
Short %
info
3.80%
Management effectiveness
ROE (TTM)
info
8.71%
ROA (TTM)
info
4.61%
Profit margin
info
14.27%
Gross profit margin
info
$4.92B
Operating margin
info
18.00%
Growth
Quarterly earnings growth (YoY)
info
59.70%
Quarterly revenue growth (YoY)
info
4.00%
Share stats
Outstanding Shares
info
199M
Float
info
199M
Insiders %
info
0.14%
Institutions %
info
93.29%
Analyst Insights & forecasts
info

34% Buy

60% Hold

6% Sell

Based on information from 30 analysts.

Average price target

info
$124.38
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$2.20
$2.15
2.33%
Q4 • 23Beat
$1.94
$1.87
3.74%
Q1 • 24Beat
$2.01
$1.99
1.01%
Q2 • 24Beat
$1.74
$1.74
-
Q3 • 24Beat
-
-
-
Q4 • 24Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$1.94B
$243M
12.50%
Q2 • 24
$1.82B
$249M
13.66%
Q3 • 24
6.07%
2.64%
9.26%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$21.5B
$8.77B
40.76%
Q2 • 24
$21.7B
$9.34B
42.99%
Q3 • 24
0.93%
6.46%
5.48%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$369M
$-247M
$-91.9M
$264M
Q2 • 24
$396M
$-155M
$-102M
$369M
Q3 • 24
7.12%
37.29%
10.88%
39.62%
QoQ growth
QuarterlyAnnual
Sentiment analysis

-1.5

Greed

+1.5

0.55

Last 30 days

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Zimmer Biomet Holdings Inc share?
Collapse

Zimmer Biomet Holdings Inc shares are currently traded for $106.74 per share.

How many shares does Zimmer Biomet Holdings Inc have?
Collapse

Zimmer Biomet Holdings Inc currently has 199M shares.

Does Zimmer Biomet Holdings Inc pay dividends?
Collapse

Yes, Zimmer Biomet Holdings Inc does pay dividends.

What is Zimmer Biomet Holdings Inc 52 week high?
Collapse

Zimmer Biomet Holdings Inc 52 week high is $133.31.

What is Zimmer Biomet Holdings Inc 52 week low?
Collapse

Zimmer Biomet Holdings Inc 52 week low is $101.47.

What is the 200-day moving average of Zimmer Biomet Holdings Inc?
Collapse

Zimmer Biomet Holdings Inc 200-day moving average is $113.41.

Who is Zimmer Biomet Holdings Inc CEO?
Collapse

The CEO of Zimmer Biomet Holdings Inc is Ivan Tornos.

How many employees Zimmer Biomet Holdings Inc has?
Collapse

Zimmer Biomet Holdings Inc has 18,000 employees.

What is the market cap of Zimmer Biomet Holdings Inc?
Collapse

The market cap of Zimmer Biomet Holdings Inc is $21.3B.

What is the P/E of Zimmer Biomet Holdings Inc?
Collapse

The current P/E of Zimmer Biomet Holdings Inc is 20.39.

What is the EPS of Zimmer Biomet Holdings Inc?
Collapse

The EPS of Zimmer Biomet Holdings Inc is $5.24.

What is the PEG Ratio of Zimmer Biomet Holdings Inc?
Collapse

The PEG Ration of Zimmer Biomet Holdings Inc is 1.4.

What do analysts say about Zimmer Biomet Holdings Inc?
Collapse

According to the analysts Zimmer Biomet Holdings Inc is considered a hold.